Biond Biologics is an Israeli biotechnology discovery and development company.
Biond Biologics has raised €15M across 1 funding round from 3 investors, most recently a Series B round in Jan 2019. Based in Misgav, Israel; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-01-01 | Series B |
| €15M |
| Financial Services,Harel Insurance Investments,Israel Biotech Fund |
| View deal → |
